1. Home
  2. DAKT vs VOR Comparison

DAKT vs VOR Comparison

Compare DAKT & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$19.78

Market Cap

923.5M

Sector

Industrials

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$14.13

Market Cap

767.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
VOR
Founded
1968
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
923.5M
767.4M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
DAKT
VOR
Price
$19.78
$14.13
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$45.33
AVG Volume (30 Days)
294.6K
1.3M
Earning Date
03-04-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.75
N/A
Revenue
$608,932,000.00
N/A
Revenue This Year
$12.06
N/A
Revenue Next Year
$9.16
N/A
P/E Ratio
$26.55
N/A
Revenue Growth
6.89
N/A
52 Week Low
$12.37
$0.13
52 Week High
$28.27
$49.95

Technical Indicators

Market Signals
Indicator
DAKT
VOR
Relative Strength Index (RSI) 46.80 44.43
Support Level $19.76 $11.74
Resistance Level $20.67 $14.73
Average True Range (ATR) 0.53 1.11
MACD 0.17 -0.27
Stochastic Oscillator 48.21 12.47

Price Performance

Historical Comparison
DAKT
VOR

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: